Eaton Vance Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Eaton Vance Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,753	Closed	-$79K	–	3071
2021 Q1	$79K	Buy	+1,753	New	+$81.6K	﹤0.01%	1661
2020 Q3	–	Sell	-51,373	Closed	-$3.07M	–	1343
2020 Q2	$3.07M	Sell	51,373 -73,543	-59%	-$3.93M	0.01%	715
2020 Q1	$5.14M	Buy	124,916 +30,346	+32%	+$1.68M	0.01%	539
2019 Q4	$5.89M	Buy	+94,570	New	+$4.49M	0.01%	572

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Eaton Vance Management's DCPH Position: Q2 2021 in Review

Eaton Vance Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 1,753 shares — an estimated $79K sold.

Eaton Vance Management first reported a position in DCPH in Q4 2019 and held it in 4 quarters. The position peaked at $5.89M in Q4 2019. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Eaton Vance Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Eaton Vance Management sold 1,753 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $79K.
Eaton Vance Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Eaton Vance Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.89M in Q4 2019.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.